<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Ltd (formerly Roxy Exports Limited) has submitted an initial disclosure to BSE under SEBI's Large Corporate framework (circular dated November 26, 2018). The company has declared that it does not fall under the 'Large Corporate' category as defined in the circular, so the related borrowing and compliance requirements do not apply to it. The filing confirms that the company's outstanding long-term borrowings (other than ECB) as on 31 March 2025 were NIL. Credit rating and exchange details for shortfall penalties are marked as Not Applicable, since the framework itself doesn't apply. The disclosure was signed by Adarsh Munjal, Whole Time Director, on April 26, 2025.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms that Remedium Lifecare is a small-cap company with no significant long-term debt and is exempt from the Large Corporate obligations.